Literature DB >> 20438412

Differential diagnosis of renal tumours with clear cell histology.

Victor E Reuter1, Satish K Tickoo.   

Abstract

Clear cell renal cell carcinoma is the most common malignant renal epithelial tumour and constitutes 90% of cases that metastasise. Nevertheless, it is important to recognise that not all clear cell carcinomas contain a preponderance of clear cells and that other renal tumours with different biologies and sensitivities to systemic therapeutic agents may exhibit clear cell cytology. Close attention to the cytological and growth pattern characteristics will allow us to arrive at the proper diagnosis, sometimes with the aid of immunohistochemistry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20438412     DOI: 10.3109/00313021003785746

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  15 in total

1.  Renal tumors: diagnostic and prognostic biomarkers.

Authors:  Puay Hoon Tan; Liang Cheng; Nathalie Rioux-Leclercq; Maria J Merino; George Netto; Victor E Reuter; Steven S Shen; David J Grignon; Rodolfo Montironi; Lars Egevad; John R Srigley; Brett Delahunt; Holger Moch
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

2.  Differentiation of Clear Cell Renal Cell Carcinoma From Other Renal Cortical Tumors by Use of a Quantitative Multiparametric MRI Approach.

Authors:  Andreas M Hötker; Yousef Mazaheri; Andreas Wibmer; Christoph A Karlo; Junting Zheng; Chaya S Moskowitz; Satish K Tickoo; Paul Russo; Hedvig Hricak; Oguz Akin
Journal:  AJR Am J Roentgenol       Date:  2017-01-17       Impact factor: 3.959

Review 3.  Renal cell carcinoma.

Authors:  James J Hsieh; Mark P Purdue; Sabina Signoretti; Charles Swanton; Laurence Albiges; Manuela Schmidinger; Daniel Y Heng; James Larkin; Vincenzo Ficarra
Journal:  Nat Rev Dis Primers       Date:  2017-03-09       Impact factor: 52.329

Review 4.  Interpretation of needle biopsies of the kidney for investigation of renal masses.

Authors:  Benoît Lhermitte; Laurence de Leval
Journal:  Virchows Arch       Date:  2012-06-08       Impact factor: 4.064

5.  Intratumoral Resolution of Driver Gene Mutation Heterogeneity in Renal Cancer Using Deep Learning.

Authors:  Paul H Acosta; Vandana Panwar; Vipul Jarmale; Alana Christie; Jay Jasti; Vitaly Margulis; Dinesh Rakheja; John Cheville; Bradley C Leibovich; Alexander Parker; James Brugarolas; Payal Kapur; Satwik Rajaram
Journal:  Cancer Res       Date:  2022-08-03       Impact factor: 13.312

6.  MR imaging of renal cortical tumours: qualitative and quantitative chemical shift imaging parameters.

Authors:  Christoph A Karlo; Olivio F Donati; Irene A Burger; Junting Zheng; Chaya S Moskowitz; Hedvig Hricak; Oguz Akin
Journal:  Eur Radiol       Date:  2013-01-10       Impact factor: 5.315

Review 7.  Renal cancer biomarkers: the promise of personalized care.

Authors:  Naveen S Vasudev; Peter J Selby; Rosamonde E Banks
Journal:  BMC Med       Date:  2012-09-27       Impact factor: 8.775

8.  Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity.

Authors:  Rosalie Fisher; James Larkin; Charles Swanton
Journal:  EPMA J       Date:  2011-12-22       Impact factor: 6.543

9.  What morphology can teach us about renal cell carcinoma clonal evolution.

Authors:  Payal Kapur; Alana Christie; Satwik Rajaram; James Brugarolas
Journal:  Kidney Cancer J       Date:  2020-09

Review 10.  Renal Cell Carcinoma in the Era of Precision Medicine: From Molecular Pathology to Tissue-Based Biomarkers.

Authors:  Sabina Signoretti; Abdallah Flaifel; Ying-Bei Chen; Victor E Reuter
Journal:  J Clin Oncol       Date:  2018-10-29       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.